Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Public ClinicalTrials.gov record NCT02188368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of Pomalidomide as a Replacement for Lenalidomide for Multiple Myeloma Patients Relapsed or Refractory to a Lenalidomide-Containing Combination Regimen
Study identification
- NCT ID
- NCT02188368
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Oncotherapeutics
- Industry
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Interventions
- BTZ Drug
- CFZ Drug
- CLA Drug
- CY Drug
- PLD Drug
- POM Drug
- Steroids Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 6, 2014
- Primary completion
- Oct 22, 2020
- Completion
- Oct 22, 2020
- Last update posted
- Nov 2, 2023
2014 – 2020
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Associates for Research & Excellence (cCARE) | Encinitas | California | 92024 | — |
| Compassionate Care Research Group | Fountain Valley | California | 92708 | — |
| Comprehensive Cancer Center at Desert Regional Medical Center | Palm Springs | California | 92262 | — |
| Inland Hematology Oncology Medical Group, Inc | San Bernardino | California | 92404 | — |
| Wellness Oncology and Hematology | West Hills | California | 91307 | — |
| James R. Berenson, MD, Inc. | West Hollywood | California | 90069 | — |
| VA Sierra Nevada | Reno | Nevada | 89502 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Rapid City Regional Hospital | Rapid City | South Dakota | 57701 | — |
| Wellmont Medical Associates Oncology and Hematology | Kingsport | Tennessee | 37660 | — |
| Vista Oncology | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02188368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2023 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02188368 live on ClinicalTrials.gov.